Literature DB >> 1260728

Prostatic carcinoma: some morphological features affecting prognosis.

N A Epstein, L P Fatti.   

Abstract

Morphologic features in 146 cases of prostatic carcinoma were correlated with 5-year survival. Simple probability tests showed a significant prognostic difference of the presence or absence of cell borders, lymphocytic infiltration, pleomorphism of nuclei, and McNeal's typing. Further statistical analysis, with a probability test which was adjusted for the distribution of these factors, showed that only the presence or absence of cell borders and lymphocytic infiltration affected prognosis. It is very important for the pathologist reporting on prostate carcinoma to include mention of these factors in his report because of their prognostic importance. In particular it should be noted that if the tumor has indistinct cell borders and there is no lymphocytic infiltration, then it is likely to have a very poor prognosis.

Entities:  

Mesh:

Year:  1976        PMID: 1260728     DOI: 10.1002/1097-0142(197605)37:5<2455::aid-cncr2820370539>3.0.co;2-v

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  5 in total

1.  Urology: clinicopathologic features of unsuspected lymph node metastases in prostatic carcinoma.

Authors:  S L Saltzstein; A P McLaughlin
Journal:  West J Med       Date:  1977-01

2.  Aneuploidy of glandular epithelial cells in histologically normal prostate glands.

Authors:  T I Malinin; F J Hornicek; N L Block; G I Malinin
Journal:  Experientia       Date:  1988-03-15

3.  Cell kinetic and cytological grading of prostatic carcinoma.

Authors:  B Helpap
Journal:  Virchows Arch A Pathol Anat Histol       Date:  1981

4.  A cellular automaton model examining the effects of oxygen, hydrogen ions and lactate on early tumour growth.

Authors:  Maymona Al-Husari; Craig Murdoch; Steven D Webb
Journal:  J Math Biol       Date:  2013-08-28       Impact factor: 2.259

Review 5.  The concept of immune surveillance against tumors. The first theories.

Authors:  Domenico Ribatti
Journal:  Oncotarget       Date:  2017-01-24
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.